The University of Houston is one of the best schools for your money. Photo courtesy of University of Houston

A Houston school is among the head of the class when it comes to bang for your buck. This, according to a recent survey from College Factual, which ranked the best colleges for your money in the Southwest.

The University of Houston comes in at No. 7 on College Factual's list. Seven Texas colleges also score high marks.

Austin College in Sherman, north of Dallas, took the No. 2 spot on the list, and is the highest-ranked Texas college. Following it are Texas Tech University (No. 3), St. Mary's University in San Antonio (No. 5), Texas Lutheran University in Seguin (No. 6), Southwestern University in Georgetown (No. 8), and Trinity University in San Antonio (No. 9).

The three non-Texas colleges that joined them in the top 10?

Ranking first in the Southwest region was St. John's College in Santa Fe, followed by Oklahoma City University (No. 4) and University of Tulsa (No. 10).

To come up with the rankings, College Factual analyzed over 2,000 colleges and universities to determine which ones are best in a variety of categories, such as overall value, quality, diversity, and which schools are the best for each major.

For example, St. Mary's University, a Marist liberal arts school located on the West Side of San Antonio, earned 28 badges, and its highest-ranked major was business administration and marketing. With an average tuition cost of $26,726 and an average of 4.2 years to graduate, St. Mary's earned the No. 5 spot in the Southwest and third in Texas. The study also highlighted the school's 12-to-1 faculty to student ratio, better than the national 15-to-1 average.

Austin College, which landed ahead of St. Mary's at No. 2, is a small, private not-for-profit school that awarded 342 bachelor's degrees in 2018-2019, the report says.

"It takes about 4.1 years for the average student at Austin College to complete their degree, and on average, the annual cost to attend the school is $27,662," they say. "Thus, the average cost to get a bachelor's degree from the Austin College is $112,861. Graduating sooner can prevent you from having to pay more money out of pocket."

Much larger Texas Tech University, No. 3 in the rankings, awarded 6,599 bachelor's degrees in 2018-2019.

"You'll join some of the best and brightest minds around if you attend Texas Tech University," the report says. "The average student at Texas Tech graduates in less than 4.5 years, and it costs about $26,528 per year to attend the school. This means that the average student pays around $119,907 to get a bachelor's degree from Texas Tech. The sooner a student graduates, the more money they can save."

It's been a banner year for the University of Houston, which just raised a massive $1.2 billion in a recent capital campaign.

Read the entire report here.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.